Protection, Health and Care 2018 Conference

The growing cohort of people aged 65+ is rich in diversity, with aspirations, concerns and preparedness for the future differing vastly from group-to-group; individual-to-individual. Yet, as an insurance industry, we've largely used a product- or risk-led "one size fits all" approach for people's later life needs with a strong focus on attempting to develop a long-term care market. A number of forward-thinking insurers are starting to approach this growing demographic differently. As a result, Swiss Re has carried out extensive ageing consumer research in 9 markets – including the UK – and it reveals exciting opportunities to increase the industry's share of the later-life wallet.

We will share the research and gain expert insight into what it means for insurance and wider UK policy from Steve Webb – Policy Director at Royal London and Pensions Minister 2010-15.

Speakers: Matt Singleton, Swiss Re and Sir Steve Webb, Director of Policy, Royal London and Pensions Minister 2010-15

Only for those who have not already registered

John Graham, Chair CPD Committee 2018

Marjorie Ngwenya, President, Institute and Faculty of Actuaries

Speaker: Raj Jethwa, Director of Policy, BMA 

A1:  Innovations abroad - the South African market

South Africa is arguably one of the most innovative life insurance markets in the world and the local providers have continually pushed the boundaries on product development aimed at meeting the needs of their end customers. The demographics of South Africa have shaped product design and as a result propositions have been designed to cater to all consumer segments from the high net worth customer all the way down to offerings for the poorer sections of society. This talk looks at what has driven innovation within the South African market and how do insurers continue to compete in this space.

Speakers: Damien Bartlett, Deputy CEO SCOR Global Life UK and Emma Denby, Senior Actuarial Analyst Client Propositions, SCOR

A2:  Modelling Antibiotic resistance - IFoA working party

Antibiotic resistance (ABR) has become a growing concern to health services as well as to insurers and reinsurers from a mortality and morbidity perspective.  This session presents the final results of the IFoA ABR working party. We present our modelling approach (the model will be available to IFoA members), including the derivation of parameters for the model, and share the results of applying the model to the practical example of a (notional) life insurance portfolio. We also provide appropriate medical background and consider emerging developments in the field.

Speakers: Matthew Edwards, Willis Towers Watson, Nicola Oliver, Medical Intelligence and Sheridan Fitzgibbon, L&G

A3:  Using English National Dataset to estimate Models of Functional Disability

An important and fundamental input to the pricing of LTC insurance products is a set of age and sex-specific functional status transition rates that can flexibly take into account alternative benefit trigger specifications. I apply generalized linear models to evaluate disability transitions for individuals in old age using two English National Longitudinal datasets.

Speaker: Mohamed Elsheemy, Pricing Analyst, NHS England

B1: IP for the gig economy: what we have learned 5000 claims later

Short deferred IP for manual occupations has long been the main stay of niche providers; however the rise of the Gig economy over recent years has increased the consumer need for access to affordable income protection.In 2014 LV= launched Personal Sick Pay (PSP) to address these needs. The product quickly gained traction in the market with both advisors and consumers.  In this talk we will discuss the product design as well as the risk management considerations of bringing income protection to a new demographic in an evolving economic environment.

Speakers: Zoe Woodroffe, Pricing Actuary, Gen Re and Joanne Wells LV=

B2:  A new Dutch term assurance product – Innovation or back to basics?

Case study: Five years ago a new term assurance product was launched in the Dutch market. Rather than a level premium the policyholder pays a risk based premium which increases with age. The session will explain the product, its benefits and consequences, use of technology and distribution across sales channels interspersed with some antidotes on Dutch life and background on the Dutch life protection market.

Speaker: Elaine Turner, Senior Manager & Marketing Actuary, Achmea Reinsurance

B3:   Do new genetic technologies pose an existential threat to products like CI

A look at new technologies like whole gene sequencing and its implications on products based on diagnosis and not prognosis.  Also how do we avoid creating a genetic underclass? 

Speaker: Paul Edwards, Manager Medical Risk Research, Hannover Re UK Life Branch

M1: Gravitas Levitas

Some people have a natural authority that’s often called gravitas. When they speak others listen. When they walk into a room others take notice. Others have levitas – a playful quality that can lighten the mood.

Some people can exhibit both gravitas and levitas, but many default to one or the other – while some come across as bland, lacking either characteristic. This workshop will help them continue their professional development by giving them a thorough understanding of gravitas and levitas – what they are, why they matter and how to go about developing them.

Speaker: Michael Brooke, Speak First

M2: Strategic Networking

Successful networking is about taking a strategic approach rather than relying on chance. You need to be clear about your ultimate purpose and develop a structured plan for achieving it. This session will cover both face-to-face networking and how to build a strong personal brand via social media. Participants will leave with increased confidence in their ability to become the person that people want to speak to, know how to connect with others in both formal and online situations, and have an action plan for making the most of future networking opportunities.

Speaker: Geoffrey Jarvis, Speak First

M3:  Using EI to Better Manage Actuarial Teams

This talk covers how to use your emotional intelligence in the workplace, with a particular focus on understanding and managing other people more effectively, and is aimed at people who lead actuarial and finance teams.

We'll be covering the following;

• Millennials in the workplace - managing different generations
• A model for political awareness (foxes, donkeys and owls)
• How to deal with the walking dead and the well poisoners
• Plus lots more!

This will be a thought provoking and practical talk that will challenge you to approach your team management differently. 

Speakers: Peter Heffernan, Associate Director, PwC and Michelle Lister, Associate Director, PwC

The field of Behavioural Economics (BE) remains a key focus in both the public and private sector. Employing a rigorous test-and-learn approach of running live field trials to better understand and predict what's driving customer behaviour, BE is relevant across the insurance value chain. Co-presented by Swiss Re's market leading Behavioural Research Unit, and Aviva's Customer Accelerator, our discussion will focus on the role BE can play in understanding and influencing insurance customer related behaviours including sharing case studies with the results and business impact. 

Speakers: Alison McLean, Head of Behavioural Research, Swiss Re and Louise Colley, Customer Accelerator Director, Aviva

C1:   What if we find a cure for obesity?

With nearly two thirds of adults in the UK classified as overweight or obese and the overall prevalence projected to rise in the future, obesity is a key issue for Public Health England to tackle.  The rising trends in obesity is a key issue for insures too, since long-term Life and CI cover provided with initial underwriting leads insurers exposed to higher mortality and morbidity risk.We provide a summary of the current UK obesity statistics and explore the clinical links to higher insurance risk.  We take a look at the existing approaches used to tackle obesity and ask what the insurance implications are, if we find a cure for obesity.

Speaker: Nay Wynn, Actuary, Research, Hannover Re

C2:   CMI Income Protection experience and new graduations

The CMI Income Protection Committee will present an update on its recent work on individual income protection, including:

•  Draft graduations of 2003-2010 experience, to replace the IPM 1991-98 graduations

•  Expanding the graduations to reflect experience for both males and females, and all occupation classes

•  Other features of recent experience, including by benefit amount and policy duration

•  Future plans

Speakers: Duncan Heald, Head Of Corporate Actuarial, SCOR Global Life SE and Mark Paulson, CMI Secretariat

C3:  “ProTECHtion”: New business models in a new world

This session considers how Digitalization and AI can transform the insurance business model. We will make a journey into the ecosystem that enables the insurer to offer a different benefit proposition to the end customer. We will cover this in two parts:

Part A

• Digital protection landscape with a focus on health that enables insurers to transition from “claims payer” to “care taker”
• Integrated offerings of flexible and dynamic services and products
• Personal portals tailor made to enhance customer centricity.

Part B

• Capitalize on available data and the power of AI & Advanced Analytics to optimize the Insurance Value Chain and Customer Journey.

Speakers: Luca De Sanctis, EY; Roberto Ascione, Healthware; Constantinos  Rossides and Dimitrios Velmachos, EY

Workshop 1: The new Actuaries’ Code and proposals in relation to the monitoring of actuarial work

This session will provide an update on, and insight into, changes to the Actuaries’ Code that will come into effect in summer 2019. The Actuaries’ Code is the key ethical standard for IFoA members and it is important that they are up to date on the changes proposed. The session will also cover other important changes to the IFoA’s regulation of its members, including proposals to introduce some proportionate, risk based monitoring of actuarial work.

Speakers: Emma Gilpin, Head of Regulatory Policy and Judith Joy, Regulatory Lawyer, IFoA

Workshop 2: Critical illness insurance rates and pricing: are they changing over time and how?

In this work we consider changes over time in Critical illness Insurance (CII) rates and pricing, based on data provided by the CMI for the years 1999 to 2005 and 2007 to 2010. Better understanding of changes and uncertainty in CII rates and pricing is important, not least because of issues related to data availability, medical advances leading to more efficient diagnosis or treatment, and new trends in emerging policy products. We estimate CII rates for the two periods using robust statistical modelling (based on Generalised Linear Model methodology) and allow for parameter and model uncertainty.  The distribution of the time between diagnosis and settlement of a claim is also taken into account, to allow Incurred-but-not-Settled adjustments in the analysis. We provide rates for both accelerated and stand-alone policies, and for a wide range of ages. Our results show changes of CII rates over time, with variations being idiosyncratic to particular characteristics including policy type and duration, sum assured and age, gender and smoking status of policyholder. In the talk we will also discuss comparisons of our results to rates obtained by the CMI.

Speakers: Dr George Streftaris, Heriot-Watt University and Dr Erengul Dodd, University of Southampton

Conference dinner (19.30) and after dinner speaker, Hannah Fry (21.30)

Edison said in 1903 “The doctor of the future will give no medicine, but will instruct his patient in the care of the human frame, in diet and in the cause and prevention of disease”. This was the original aim of the NHS, and could we now be entering that era?  We have a better understanding of modern disease (diabetes, heart disease, hypertension, cancer, obesity), and cures are on the horizon.  We need to move (back) into managing lifestyle factors.  The presentation will cover:

• Where does this leave Health & Protection Insurance?

• The economic and social implications of people living as long as they want, with potential to slow ageing further with biomedical gerontology.  •What products can the industry offer to help this evolution (and what is our ethical responsibility)?  

• Is focus on wellbeing and prevention key – de-medicalising how we think, to realise what Edison was referring to?

• How do we think holistically about Nutrition, Sleep, Mental Health and fitness?  •How do we use behavioural economics to change behaviour and impact health?

• What will Insurance look like in 2050? How do we begin now, in the next 5-10 years, and beyond?

Technical Knowledge: The technical knowledge of the session is general knowledge of Health & Protection Insurance, with current product knowledge.oWe will consider Behavioural Economics, Economic Uncertainty and impact on customers, Emerging Risks/Horizon Scanning (eg new products, cures of all modern disease, business risk)

Speakers:  Richard Galbraith, Senior Enterprise Risk Manager, Aviva and Dr Doug Wright, UK Health, Aviva

D1:   Critical illness: emerging trends

Medical developments continue apace, with recent innovation including, inter alia, "breath biopsies"; and a bra that detects cancer. This presentation will look at the latest trends in disease incidence and diagnosis and consider the pricing challenges for critical illness that are emerging as a result.

Speakers: Nisha Price, Pricing Actuary, Swiss Re and Aisling Kennedy, Swiss Re

D2:   InsurTech: How do insurers assess the risks and opportunities?

Insurers have begun investing significant amounts of time and money into developing and acquiring new InsurTech solutions that can enhance their propositions and help maintain a competitive advantage. But how are insurers assessing the risks from investing in InsurTech, what gaps in knowledge do insurers have, and what tools could be developed? The Risk Management in a Digital World Working Party will discuss the results of a recent survey on how insurers are responding to the opportunities and risks from InsurTech, and also present a new checklist to help those who are assessing InsurTech opportunities.

Speakers: Richard Purcell, Technical & Innovation Lead, Hymans Robertson and Daniel Bruce, Partner Crowe Horwath

D3:   Wearables and the Internet of Things: Working Group Report

The Wearables and Internet of Things Working Group presents its report on findings about the role that technology will play in the insurance sector. The report includes-the accuracy and reliability of measures available from technology-suggested uses by stakeholder of the technology-case studies and lessons learned from existing users.This session is accessible by actuaries and students of all levels wanting to understand how technology might impact the insurance products of the future. 

Speakers: Anna Spender, Pyson and Colin Bullen, Habits at Work

E1:    Reinventing CI - An Asian Case Study

In a world of increasingly sophisticated and confusing CI products we have stopped as asked whether the product remains fit for purpose.  Is there a way to make CI simpler?  Together with a partner in Asia we have tried to move from a product which pays on diagnosis of a medical condition to one that pays when the policyholder is critically ill. Join us as we describe our approach, discuss the challenges we faced and provide an overview of the final product. 

Speakers: Chris Reynolds, PartnerRe and Achim Regenauer, PartnerRe

E2:    Early Intervention and Prevention - the Changing Face of Health Cash Plans

Health cash plans engage with customers on a regular basis (average claim per customer twice per year) and we have a wealth of insights to share.  It’s been 10 years since I last presented at this forum and things have moved on to reflect the changes in Society, both in the work and family environment.  

Speakers: Courtney Marsh, Health Shield Friendly and Jennie Doyle, Health Shield Friendly

E3:    Insuring heat-not-burn e-cigarette smokers           

The effects of e-cigarettes are a hot topic for protection pricing.  The field has recently seen the emergence of new ‘heat not burn’ e-cigarettes, completely different from vaping products.  This session explores Phillip Morris International’s ‘heat not burn’ product IQOS.  The session will consider the biomarker evidence available relating to the product, and make reference to independent medical opinions and also consider behavioural aspects (eg improved switching behaviour, socio-economic profile).

Speakers: Matthew Edwards, Willis Towers Watson, Richard Marshall, Willis Towers Watson and Thomas McGrath, Phillip Morris International

Chair: Joan Coverson, Gen Re

Panellists: Adam Jones, Vitality; Adrian Baskir, Bupa and Gary Beyer, Royal London

Video case studies and other materials will be used to explore issues raised under the theme of "Actuarial Interaction and Challenge" both inside and outside the office.  The session will be interactive and facilitated by Malcolm Slee and Richard Galbraith of the IFoA's Professional Skills Working Party.  Come prepared to contribute your views to the discussion.  The session may be counted towards meeting your Stage 3 PST requirements under the IFoA's CPD Scheme 2017/18.

Speakers: Malcolm Slee and Richard Galbraith  Aviva Life Services UK Limited